Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,220.83
1,119.74
1,190.39
1,153.67
1,166.93
1,054.34
1,043.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,220.83
1,119.74
1,190.39
1,153.67
1,166.93
1,054.34
1,043.50
Raw Material Cost
429.76
260.58
269.73
476.58
409.15
320.43
314.06
Purchase of Finished goods
41.80
120.91
231.60
133.77
173.04
149.67
148.92
(Increase) / Decrease In Stocks
43.71
62.79
-2.36
-130.23
-31.16
-20.25
-30.70
Employee Cost
226.78
225.52
222.86
215.64
215.70
208.55
194.26
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.00
-0.01
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
247.23
231.86
250.70
247.60
215.61
205.91
212.64
Total Expenditure (Excl Depreciation)
989.27
901.66
972.53
943.36
982.33
864.32
839.18
Operating Profit (PBDIT) excl Other Income
231.56
218.08
217.86
210.31
184.60
190.02
204.32
Other Income
27.14
8.58
11.98
5.62
28.41
12.72
-13.55
Operating Profit (PBDIT)
258.70
226.66
229.84
215.93
213.01
202.74
190.77
Interest
46.13
47.46
50.32
52.18
73.82
72.52
71.10
Exceptional Items
-8.77
-8.37
-27.42
-2.43
-3.87
3,286.49
-13.79
Gross Profit (PBDT)
203.80
170.83
152.10
161.32
135.32
228.60
111.60
Depreciation
49.64
48.89
48.86
48.42
48.45
46.52
47.94
Profit Before Tax
153.12
122.04
106.38
113.85
86.21
180.49
28.68
Tax
21.59
16.45
20.76
23.81
13.94
19.02
12.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
132.57
105.49
82.49
89.09
72.93
163.05
51.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
3,188.11
-5.72
Net Profit
132.57
105.49
82.49
89.09
72.93
3,351.16
45.42
Share in Profit of Associates
-1.05
0.10
3.13
0.95
-0.66
-1.58
-34.98
Minority Interest
3.99
5.99
3.42
2.09
0.43
-1.89
-7.73
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
127.53
99.61
82.19
87.95
71.84
3,351.47
18.18
Equity Capital
92.17
92.16
92.16
92.16
91.96
91.90
91.90
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
13.84
10.81
8.92
9.54
3.42
159.81
0.87
Diluted Earnings per share
13.84
10.81
8.92
9.55
3.42
159.49
0.87
Operating Profit Margin (Excl OI)
18.97%
19.48%
18.3%
18.23%
15.82%
18.02%
19.58%
Gross Profit Margin
16.69%
15.26%
12.78%
13.98%
11.6%
21.68%
10.69%
PAT Margin
10.77%
9.43%
7.19%
7.8%
6.19%
15.31%
1.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 4.62% vs 16.76% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 77.52% vs 154.70% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 25.44% vs 20.55% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -37.51% vs -6.07% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Strides Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
1,220.83
720.41
500.42
69.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,220.83
720.41
500.42
69.46%
Raw Material Cost
429.76
227.72
202.04
88.72%
Purchase of Finished goods
41.80
106.14
-64.34
-60.62%
(Increase) / Decrease In Stocks
43.71
-25.27
68.98
272.97%
Employee Cost
226.78
103.80
122.98
118.48%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
247.23
163.52
83.71
51.19%
Total Expenditure (Excl Depreciation)
989.27
575.91
413.36
71.78%
Operating Profit (PBDIT) excl Other Income
231.56
144.50
87.06
60.25%
Other Income
27.14
21.57
5.57
25.82%
Operating Profit (PBDIT)
258.70
166.07
92.63
55.78%
Interest
46.13
5.82
40.31
692.61%
Exceptional Items
-8.77
0.00
-8.77
Gross Profit (PBDT)
203.80
160.25
43.55
27.18%
Depreciation
49.64
26.92
22.72
84.40%
Profit Before Tax
153.12
133.33
19.79
14.84%
Tax
21.59
34.20
-12.61
-36.87%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
132.57
99.14
33.43
33.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
132.57
99.14
33.43
33.72%
Share in Profit of Associates
-1.05
0.00
-1.05
Minority Interest
3.99
0.89
3.10
348.31%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
127.53
98.25
29.28
29.80%
Equity Capital
92.17
45.32
46.85
103.38%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
13.84
2.17
11.67
537.79%
Diluted Earnings per share
13.84
2.17
11.67
537.79%
Operating Profit Margin (Excl OI)
18.97%
20.06%
0.00
-1.09%
Gross Profit Margin
16.69%
22.24%
0.00
-5.55%
PAT Margin
10.77%
13.76%
0.00
-2.99%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,220.83 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 9.03% vs -5.94% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 4.62% vs 16.76% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 127.53 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 28.03% vs 21.19% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 77.52% vs 154.70% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 231.56 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 6.18% vs 0.10% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 25.44% vs 20.55% in Sep 2024
Quarterly - Interest
Interest 46.13 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is -2.80% vs -5.68% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -37.51% vs -6.07% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.97%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
